Singapore invests $37.1m for precision oncology research | Healthcare Asia Magazine
, Singapore
Photo from National Cancer Institute on Unsplash

Singapore invests $37.1m for precision oncology research

Two research programmes on lymphoma and colorectal cancer have received $18.5m (S$25m) each.

The Ministry of Health (MoH). through the National Medical Research Council (NMRC), Office, MOH Holdings, Pte Ltd, has invested $37.1m (S$50m) to advance precision oncology research in Singapore.

The investment, under the NMRC Open Fund-Large Collaborative Grant (OF-LCG) programme, supports two multi-institution and multidisciplinary teams, each receiving a grant of $18.5m (S$25m) for their research programmes.

ALSO READ: Singapore healthcare needs collective and progressive action for sustainability

One of the programmes, “SYMPHONY 2.0,” led by the National Cancer Centre Singapore (NCCS), aims to develop cost-effective, accessible, and new treatment modalities to address Asian-centric lymphomas.

Meanwhile, the “Colo-SCRIPT” programme co-led by NCCS and A*STAR will focus on colorectal cancer through a subtype-specific approach to implement prevention and early detection strategies, and test novel therapies in clinical trials.

S$1 = $0.74

 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!